image
A young, gloved boxer punching forward
eyebrow
Cancer awareness
headline

Taking the stage at the Big Game

content
Cancer remains one of the biggest health challenges of our lifetime. Our latest campaign represents more than a message; it is a rallying cry for our unwavering commitment to breakthroughs that transform lives, empowering people to take charge of their health. It aligns with our mission to not only lead the way in cancer innovation, but also to inspire a united, community-wide effort to knock out cancer as we know it.
image
A young, gloved boxer with raised arms
headline

Knowledge is power

content
To drive real change in cancer, we need more people to join the fight. Through our long-standing partnership with the American Cancer Society® (ACS), we’re helping patients at every stage of their cancer journey. Our latest campaign points you to PfizerForAll, where you can take the ACS CancerRisk360™ for actions you can take to help lower your cancer risks, including regular screenings.
buttons
Explore more
image
A lab technician making notes
headline

Shaping the future of

cancer care

content

Pfizer has a deep pipeline of potential new cancer medicines. We’re fighting to deliver at least 8 potential breakthroughs in cancer care by 2030, which would have the potential to make a significant impact for people living with cancer.

However, we know that breakthrough medicines can’t make an impact if the people who need them can’t get them. We also work with the oncology community to reach patients faster—by addressing barriers to access and tackling inequities in care, and providing patients and caregivers with support and resources across their cancer journey.

Pfizer is proud to be recently named 2024 Corporate Partner of the Year by the American Cancer Society, in recognition of our longstanding partnership in addressing unmet needs and tackling inequities in cancer. The award reflects Pfizer’s and ACS’s strong collaboration over a number of years on a number of initiatives and programs that reflect the organizations’ shared priorities, and we look forward to our continuing collaboration.